Showing results (101-110 of 201) with videos related to
Sort By:
Pageof 21
Nature Communications|August 13, 2020
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-KynurenineLuis Felipe Campesato, Sadna Budhu, Jeremy Tchaicha, et al.Nature Medicine|April 23, 2024
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analysesClaire F Friedman, Beryl L Manning-Geist, Qin Zhou, et al.Cell|August 26, 2017
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer PatientAlejandro Jiménez-Sánchez, Danish Memon, Stephane Pourpe, et al.Gynecologic Oncology|November 3, 2020
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancersMaria M Rubinstein, Rachel N Grisham, Karen Cadoo, et al.Cell|October 31, 2024
Ovarian cancer-derived IL-4 promotes immunotherapy resistanceGurkan Mollaoglu, Alexander Tepper, Chiara Falcomatà, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2019
PD-1 Blockade in Advanced Adrenocortical CarcinomaNitya Raj, Youyun Zheng, Virginia Kelly, et al.Gynecologic Oncology|November 25, 2018
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockadeJulia L Boland, Qin Zhou, Madhuri Martin, et al.Gynecologic Oncology|November 12, 2021
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancerBeryl L Manning-Geist, Sushmita B Gordhandas, Dilip D Giri, et al.Gynecologic Oncology|December 13, 2022
Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 studyMaria M Rubinstein, Eric Rios Doria, Jason Konner, et al.Arthritis Care & Research|August 15, 2015
Differential Association of Psychosocial Comorbidities With Subclinical Atherosclerosis in Rheumatoid ArthritisYing L Liu, Moyses Szklo, Karina W Davidson, et al.Pageof 21